Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Double-Blind, Randomized, Crossover Study in Older Healthy Subjects to Compare the Safety, Tolerability, and Pharmacokinetics of Lyt-100 (Deupirfenidone) to Pirfenidone

NCT07456800 is registered in ClinicalTrials.gov with PureTech as lead sponsor.

NCT NCT07456800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07456800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Double-Blind, Randomized, Crossover Study in Older Healthy Subjects to Compare the Safety, Tolerability, and Pharmacokinetics of Lyt-100 (Deupirfenidone) to Pirfenidone
Lead sponsor
PureTech
Phase
Phase 1
Overall status
Completed
Start date
July 12, 2021
Completion date
January 20, 2022
Enrollment
116 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetic analysis